How Modelling Can Help Steer the Course Set by the World Health Organization 2021-2030 Roadmap on Neglected Tropical Diseases

Overview

Journal Gates Open Res

Specialties Health Services
Public Health

Date 2022 Feb 17

PMID 35169682

Authors

Jessica Clark

Wilma A Stolk

Maria-Gloria Basanez

Luc E Coffeng

Zulma M Cucunuba

Matthew A Dixon

Louise Dyson

Katie Hampson

Michael Marks

Graham F Medley

Timothy M Pollington

Joaquin M Prada

Kat S Rock

Henrik Salje

Jaspreet Toor

T Deirdre Hollingsworth

Affiliations

Soon will be listed here.

Abstract

The World Health Organization recently launched its 2021-2030 roadmap, an updated call to arms to end the suffering caused by neglected tropical diseases. Modelling and quantitative analyses played a significant role in forming these latest goals. In this collection, we discuss the insights, the resulting recommendations and identified challenges of public health modelling for 13 of the target diseases: Chagas disease, dengue, human African trypanosomiasis (gHAT), lymphatic filariasis (LF), onchocerciasis, rabies, scabies, schistosomiasis, soil-transmitted helminthiases (STH), taeniasis/ cysticercosis, trachoma, visceral leishmaniasis (VL) and yaws. This piece reflects the three cross-cutting themes identified across the collection, regarding the contribution that modelling can make to timelines, programme design, drug development and clinical trials.

Citing Articles

Effect of Adding a Six-Week Course of Doxycycline to Intensive Hygiene-Based Care for Improving Lymphedema in a Rural Setting of Mali: A Double-Blind, Randomized Controlled 24-Month Trial.

Coulibaly Y, Diabate A, Sangare M, Thera S, Dolo H, Doumbia S Am J Trop Med Hyg. 2024; 111(4_Suppl):22-32.

PMID: 39013374 PMC: 11448486. DOI: 10.4269/ajtmh.23-0908.

New Tools and Nuanced Interventions to Accelerate Achievement of the 2030 Roadmap for Neglected Tropical Diseases.

Vasconcelos A, Nunes-Alves C, Hollingsworth T Clin Infect Dis. 2024; 78(Suppl 2):S77-S82.

PMID: 38662694 PMC: 11045012. DOI: 10.1093/cid/ciae070.

Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?.

Vasconcelos A, King J, Nunes-Alves C, Anderson R, Argaw D, Basanez M Clin Infect Dis. 2024; 78(Suppl 2):S83-S92.

PMID: 38662692 PMC: 11045030. DOI: 10.1093/cid/ciae082.

Introduction to the special issue: challenges and opportunities in the fight against neglected tropical diseases: a decade from the London Declaration on NTDs.

Forbes K, Basanez M, Hollingsworth T, Anderson R Philos Trans R Soc Lond B Biol Sci. 2023; 378(1887):20220272.

PMID: 37598699 PMC: 10440167. DOI: 10.1098/rstb.2022.0272.

References

Pryce J, Reimer L . Evaluating the Diagnostic Test Accuracy of Molecular Xenomonitoring Methods for Characterizing Community Burden of Lymphatic Filariasis. Clin Infect Dis. 2021; 72(Suppl 3):S203-S209. PMC: 8201559. DOI: 10.1093/cid/ciab197. View

Aljayyoussi G, Tyrer H, Ford L, Sjoberg H, Pionnier N, Waterhouse D . Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis. Sci Rep. 2017; 7(1):210. PMC: 5428297. DOI: 10.1038/s41598-017-00322-5. View

Medley G, Blok D, Crump R, Hollingsworth T, Galvani A, Ndeffo-Mbah M . Policy Lessons From Quantitative Modeling of Leprosy. Clin Infect Dis. 2018; 66(suppl_4):S281-S285. PMC: 5982730. DOI: 10.1093/cid/ciy005. View

Abimbola S, Asthana S, Montenegro C, Guinto R, Jumbam D, Louskieter L . Addressing power asymmetries in global health: Imperatives in the wake of the COVID-19 pandemic. PLoS Med. 2021; 18(4):e1003604. PMC: 8101997. DOI: 10.1371/journal.pmed.1003604. View

Chami G, Kabatereine N, Tukahebwa E . The division of labour between community medicine distributors influences the reach of mass drug administration: A cross-sectional study in rural Uganda. PLoS Negl Trop Dis. 2019; 13(9):e0007685. PMC: 6726135. DOI: 10.1371/journal.pntd.0007685. View

Irvine M, Reimer L, Njenga S, Gunawardena S, Kelly-Hope L, Bockarie M . Modelling strategies to break transmission of lymphatic filariasis--aggregation, adherence and vector competence greatly alter elimination. Parasit Vectors. 2015; 8:547. PMC: 4618540. DOI: 10.1186/s13071-015-1152-3. View

Pinsent A, Hollingsworth T . Optimising sampling regimes and data collection to inform surveillance for trachoma control. PLoS Negl Trop Dis. 2018; 12(10):e0006531. PMC: 6181273. DOI: 10.1371/journal.pntd.0006531. View

Gambhir M, Pinsent A . Possible changes in the transmissibility of trachoma following MDA and transmission reduction: implications for the GET2020 goals. Parasit Vectors. 2015; 8:530. PMC: 4618927. DOI: 10.1186/s13071-015-1133-6. View

Rock K, Torr S, Lumbala C, Keeling M . Predicting the Impact of Intervention Strategies for Sleeping Sickness in Two High-Endemicity Health Zones of the Democratic Republic of Congo. PLoS Negl Trop Dis. 2017; 11(1):e0005162. PMC: 5215767. DOI: 10.1371/journal.pntd.0005162. View

10.

. Insights from quantitative and mathematical modelling on the proposed WHO 2030 goals for Chagas disease. Gates Open Res. 2019; 3:1539. PMC: 6856696. DOI: 10.12688/gatesopenres.13069.1. View

11.

Turner H, Walker M, Attah S, Opoku N, Awadzi K, Kuesel A . The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data. Parasit Vectors. 2015; 8:167. PMC: 4381491. DOI: 10.1186/s13071-015-0779-4. View

12.

Dixon M, Braae U, Winskill P, Walker M, Devleesschauwer B, Gabriel S . Strategies for tackling Taenia solium taeniosis/cysticercosis: A systematic review and comparison of transmission models, including an assessment of the wider Taeniidae family transmission models. PLoS Negl Trop Dis. 2019; 13(4):e0007301. PMC: 6476523. DOI: 10.1371/journal.pntd.0007301. View

13.

Le Rutte E, Coffeng L, Munoz J, de Vlas S . Modelling the impact of COVID-19-related programme interruptions on visceral leishmaniasis in India. Trans R Soc Trop Med Hyg. 2021; 115(3):229-235. PMC: 7928630. DOI: 10.1093/trstmh/trab012. View

14.

Hamley J, Blok D, Walker M, Milton P, Hopkins A, Hamill L . What does the COVID-19 pandemic mean for the next decade of onchocerciasis control and elimination?. Trans R Soc Trop Med Hyg. 2021; 115(3):269-280. PMC: 7928565. DOI: 10.1093/trstmh/traa193. View

15.

Toor J, Alsallaq R, Truscott J, Turner H, Werkman M, Gurarie D . Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?. Clin Infect Dis. 2018; 66(suppl_4):S245-S252. PMC: 5982704. DOI: 10.1093/cid/ciy001. View

16.

Kura K, Ayabina D, Toor J, Hollingsworth T, Anderson R . Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies. Trans R Soc Trop Med Hyg. 2021; 115(3):236-244. PMC: 7928593. DOI: 10.1093/trstmh/traa202. View

17.

. Insights from quantitative and mathematical modelling on the proposed 2030 goal for gambiense human African trypanosomiasis (gHAT). Gates Open Res. 2020; 3:1553. PMC: 7193711. DOI: 10.12688/gatesopenres.13070.2. View

18.

Hamley J, Walker M, Coffeng L, Milton P, de Vlas S, Stolk W . Structural Uncertainty in Onchocerciasis Transmission Models Influences the Estimation of Elimination Thresholds and Selection of Age Groups for Seromonitoring. J Infect Dis. 2020; 221(Suppl 5):S510-S518. PMC: 7289547. DOI: 10.1093/infdis/jiz674. View

19.

Michael E, Sharma S, Smith M, Touloupou P, Giardina F, Prada J . Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination. PLoS Negl Trop Dis. 2018; 12(10):e0006674. PMC: 6175292. DOI: 10.1371/journal.pntd.0006674. View

20.

Prada J, Stolk W, Davis E, Touloupou P, Sharma S, Munoz J . Delays in lymphatic filariasis elimination programmes due to COVID-19, and possible mitigation strategies. Trans R Soc Trop Med Hyg. 2021; 115(3):261-268. PMC: 7928650. DOI: 10.1093/trstmh/trab004. View